Long Noncoding RNA Signature and Disease Outcome in Estrogen Receptor-Positive Breast Cancer Patients Treated with Tamoxifen

Lignende værker

• A Long Noncoding RNA Signature That Predicts Pathological Complete Remission Rate Sensitively in Neoadjuvant Treatment of Breast Cancer()
  af: Wang, Gen, et al.
  Udgivet: (2017)
• A Potential Prognostic Long Noncoding RNA Signature to Predict Recurrence among ER-positive Breast Cancer Patients Treated with Tamoxifen
  af: Wang, Kang, et al.
  Udgivet: (2018)
• Expression signature of ten genes predicts the survival of patients with estrogen receptor positive-breast cancer that were treated with tamoxifen
  af: Huang, He, et al.
  Udgivet: (2018)
• Evaluation of the ability of adjuvant tamoxifen‐benefit gene signatures to predict outcome of hormone‐naive estrogen receptor‐positive breast cancer patients treated with tamoxifen in the advanced setting
  af: Sieuwerts, Anieta M., et al.
  Udgivet: (2014)
• Benefit of tamoxifen in estrogen receptor positive DCIS of the breast
  af: Fausto, Petrelli, et al.
  Udgivet: (2012)